Enrollment in the Phase 1/2 ASTRA study is set to start in the first half of 2025. The study will observe the safety and ...
Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and ...
The partnership revolves around Muna Therapeutics’ technology platform, which employs a spatial multi-omics approach to ...
Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...
The sickle cell gene therapies developed by Bluebird Bio and Vertex will be the first to be offered under the new scheme. A major issue with gene and cell therapies is the upfront cost. While these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback